Literature DB >> 17396105

Imatinib for the treatment of rheumatic diseases.

Ricardo T Paniagua1, William H Robinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17396105     DOI： 10.1038/ncprheum0465

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN： 1745-8382


× No keyword cloud information.
  8 in total

1.  Reduced Platelet miR-223 Induction in Kawasaki Disease Leads to Severe Coronary Artery Pathology Through a miR-223/PDGFRβ Vascular Smooth Muscle Cell Axis.

Authors:  Yuan Zhang; Yanfei Wang; Li Zhang; Luoxing Xia; Minhui Zheng; Zhi Zeng; Yingying Liu; Timur Yarovinsky; Allison C Ostriker; Xuejiao Fan; Kai Weng; Meiling Su; Ping Huang; Kathleen A Martin; John Hwa; Wai Ho Tang
Journal:  Circ Res       Date:  2020-06-29       Impact factor: 17.367

2.  Mediators of Tyrosine Phosphorylation in Innate Immunity: From Host Defense to Inflammation onto Oncogenesis.

Authors:  Kamalika Nag; Anu Chaudhary
Journal:  Curr Signal Transduct Ther       Date:  2009-05

3.  PK10453, a nonselective platelet-derived growth factor receptor inhibitor, prevents the progression of pulmonary arterial hypertension.

Authors:  Venkatrao Medarametla; Stephen Festin; Chuluunbaatar Sugarragchaa; Alexander Eng; Amir Naqwi; Timothy Wiedmann; Lawrence S Zisman
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

Review 4.  Managing macrophages in rheumatoid arthritis by reform or removal.

Authors:  Jun Li; Hui-Chen Hsu; John D Mountz
Journal:  Curr Rheumatol Rep       Date:  2012-10       Impact factor: 4.592

5.  Platelet-derived growth factor as a therapeutic target for systemic autoimmune diseases.

Authors:  Hideto Kameda; Miyuki Suzuki; Tsutomu Takeuchi
Journal:  Drug Target Insights       Date:  2007-10-30

6.  Importance of the novel organic cation transporter 1 for tyrosine kinase inhibition by saracatinib in rheumatoid arthritis synovial fibroblasts.

Authors:  Saliha Harrach; Bayram Edemir; Christian Schmidt-Lauber; Thomas Pap; Jessica Bertrand; Giuliano Ciarimboli
Journal:  Sci Rep       Date:  2017-04-28       Impact factor: 4.379

7.  Preparation and Evaluation of Imatinib Loaded Transfersomal gel for the Treatment of Rheumatoid Arthritis.

Authors:  Somayeh Taymouri; Valiollah Hajhashemi; Majid Tabbakhian; Massoud Torkashvand
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696

8.  Transport mechanisms and their pathology-induced regulation govern tyrosine kinase inhibitor delivery in rheumatoid arthritis.

Authors:  Christian Schmidt-Lauber; Saliha Harrach; Thomas Pap; Meike Fischer; Marion Victor; Marianne Heitzmann; Uwe Hansen; Manfred Fobker; Stefan-Martin Brand; Aleksandra Sindic; Hermann Pavenstädt; Bayram Edemir; Eberhard Schlatter; Jessica Bertrand; Giuliano Ciarimboli
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.